Urologic Oncology Seminars and Original Investigations Journal Citation Rate 2026
1078-1439
eISSN 1873-2496
Elsevier BV
US
Q3 Quartile
About Urologic Oncology Seminars and Original Investigations
Urologic Oncology Seminars and Original Investigations (UOSOI) is a peer-reviewed academic journal covering Bladder and Urothelial Cancer Treatments and Prostate Cancer Diagnosis and Treatment, published by Elsevier BV in US, catalogued under ISSN 1078-1439 (e-ISSN 1873-2496). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.13 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3340 USD).
Urologic Oncology Seminars and Original Investigations Citation Rate 2026 — In Context
Urologic Oncology Seminars and Original Investigations has a 2025 2-Year Citation Rate (OpenAlex) of 1.13, placing it in the Q3 quartile within the Bladder and Urothelial Cancer Treatments research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Urologic Oncology Seminars and Original Investigations operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Urologic Oncology Seminars and Original Investigations should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Urologic Oncology Seminars and Original Investigations against similar journals in the field, use our journal comparison tool.
Submission Tips for Urologic Oncology Seminars and Original …
- Budget $3340 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Urologic Oncology Seminars … Compares
Compared against 9 journals in the same research areas.
| ISSN (Print) | 1078-1439 |
|---|---|
| ISSN (Online) | 1873-2496 |
| Publisher | Elsevier BV |
| Country | United States |
| APC / Cost | $3340 USD |
In-depth profile & metrics
Urologic Oncology Seminars and Original Investigations is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3340.
In our subject taxonomy, Urologic Oncology Seminars and Original Investigations is classified under Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research and Renal cell carcinoma treatment.
Urologic Oncology Seminars and Original Investigations is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.126.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Urologic Oncology Seminars and Original …
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.126 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Urologic Oncology Seminars an… against similar publications in its field:
Related Journals in Your Field
-
World Journal of Urology Springer Science+Business Media IF 2.61
-
The Prostate Wiley IF 1.95
-
BMJ Surgery Interventions & Health Technologies BMJ IF 1.67
-
International Journal of Urology Wiley IF 1.63
-
Cancer/Radiothérapie Elsevier BV IF 1.14
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S4802544
Get weekly updates for Bladder and Urothelial Cancer Treatments journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.